BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16848872)

  • 1. Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation.
    Harada H; Miura M; Ogawa Y; Seki T; Taniguchi A; Takenouchi T; Togashi M; Hirano T
    Clin Transplant; 2006; 20 Suppl 15():26-32. PubMed ID: 16848872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
    Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
    Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cessation of steroids in stable renal transplant patients: the Leuven experience.
    Maes BD; Claes K; Coosemans W; Evenpoel P; Kuypers D; Pirenne J; Vanrenterghem Y
    Clin Transpl; 2002; ():181-9. PubMed ID: 12971448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.
    Alloway RR; Hanaway MJ; Trofe J; Boardman R; Rogers CC; Hanaway MJ; Buell JF; Munda R; Alexander JW; Thomas MJ; Roy-Chaudhury P; Cardi M; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):802-3. PubMed ID: 15848537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
    Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function.
    Weir MR; Blahut S; Drachenburg C; Young C; Papademitriou J; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Am J Nephrol; 2004; 24(4):379-86. PubMed ID: 15237243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
    Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
    Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.
    Rogers CC; Alloway RR; Boardman R; Trofe J; Hanaway MJ; Alexander JW; Roy-Chaudhury P; Buell JF; Thomas M; Susskind B; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):812-3. PubMed ID: 15848540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits derivated from late steroid withdrawal in renal transplant recipients.
    Gavela E; Avila A; Sancho A; Kanter J; Beltrán S; Crespo JF; Pallardó LM
    Transplant Proc; 2007 Sep; 39(7):2173-5. PubMed ID: 17889128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection.
    Oettl T; Zuliani E; Gaspert A; Hopfer H; Dickenmann M; Fehr T
    Transplantation; 2010 Mar; 89(6):702-6. PubMed ID: 20010328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.
    Meadows HB; Taber DJ; Pilch NA; Tischer SM; Baliga PK; Chavin KD
    Transplant Proc; 2012 Jun; 44(5):1323-8. PubMed ID: 22664009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
    Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
    Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful steroid withdrawal after long-term administration in renal transplant patients.
    Amada N; Kikuchi H; Haga I; Fukumori T; Sato A; Sato T
    Transplant Proc; 2009; 41(1):135-7. PubMed ID: 19249498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal.
    Gaber AO; Moore LW; Alloway RR; Woodle ES; Pirsch J; Shihab F; Henning A; Fitzsimmons W; Holman J; Reisfield R; First MR;
    Transplantation; 2013 Feb; 95(4):573-9. PubMed ID: 23423269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.